Digestive Surgery · 2016 · 20 citations · 29 references
MedicineOncologySurgeryGastrointestinal OncologyHepatologySurgical OncologyBiliary Tract CancerBiliary Tract DiseaseGastrointestinal Cancer SurgeryHepatobiliary CancerHepatobiliary DiseaseHepatobiliary SurgeryBile Duct Cancer SurgeryBile Duct SurgeryBiliary Tract Cancer StagingCurative InterventionGallbladder Cancer SurgeryObstructive JaundicePathological JaundiceSurvival Rates
OBJECTIVE: The aim of this study was to clarify the clinical impact of our departmental policy for advanced gallbladder cancer (GBC) even with obstructive jaundice. METHODS: Obstructive jaundice was defined as serum T-bil ≥2.0 mg/dl. Between 1998 and 2008, 112 patients with GBC were scheduled for surgical resection with curative intent. Thirty-six patients were converted to palliative surgery or exploration alone because of advanced disease. After excluding pathological T1 (UICC) patients (n = 11), the remaining 65 patients were divided into 2 groups; jaundiced group (n = 37) and non-jaundiced group (n = 28). Surgical procedures were conducted based on our departmental guidelines concerning each type of infiltration of GBC. RESULTS: Bile duct resection and major hepatectomy were performed more frequently in patients with jaundice. Although patients in jaundiced group had more advanced disease, 5-year overall survival rates of the patients with or without jaundice were 27 vs. 31% (p = 0.742), which was not statistically significant. CONCLUSIONS: Aggressive surgery might improve long-term survival in patients with locally advanced GBC even in the condition of obstructive jaundice with no distant metastasis.
29
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +12
Masato Nagino, Junichi Kamiya, Hideki Nishio et al. · Annals of Surgery · 2006 · 538 citations · Full text